Related Experiment Video

Updated: Mar 29, 2026

Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots
06:50

Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots

Published on: August 16, 2020

3.3K

Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals

Yan Ni1, Linjing Zhao1, Haoyong Yu2

  • 1Shanghai Key Laboratory of Diabetes Mellitus and Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China ; University of Hawaii Cancer Center, Honolulu, HI 96813, USA.

Ebiomedicine
|December 3, 2015
PubMed
Abstract

Keywords:
AA, arachidonic acidBMI, body mass indexCVD, cardiovascular diseaseDAG, diacylglycerolDBP, diastolic blood pressureDGLA, dihomo-gamma-linolenic acidDNL, de novo lipogenesisFATPs, fatty acid transport proteinsFFA, free fatty acidsFree fatty acidsGLA, γ-linolenic acidHA, heptadecanoic acidHDL, high-density lipoproteinHO, metabolically healthy obeseHbA1c, glycated hemoglobinInsulin resistanceLA, linoleic acidLDL, low-density lipoproteinMS, metabolic syndromeMUFA, monounsaturated acidMetabolic syndromeNAFLD, nonalcoholic fatty liver diseaseNW, normal weightOGTT, oral glucose tolerance testOPLS-DA, orthogonal partial least square discriminant analysisObesityPA, palmitoleic acidPUFA, polyunsaturated fatty acidRSD, relative standard deviationSBP, systolic blood pressureSCD, stearoyl-CoA desaturaseSFA, saturated fatty acidSHDS, the Shanghai Diabetes StudySHOS, the Shanghai Obesity StudyT2D, type 2 diabetesTC, total cholesterolTG, triglyceridesType 2 diabetesUFA, unsaturated fatty acidUO, metabolically unhealthy obeseUnsaturated fatty acidsVLCD, very low carbohydrate diet

More Related Videos

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

1.6K
Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

5.3K

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.7K